In this blog we want to keep you informed about the latest regulatory updates regarding semaglutide and tirzepatide and how RxConnexion can help your pharmacy not only navigate these changes but also maximize your dispensing potential with our innovative Telemedicine and Digital Marketing solutions.
Key FDA Updates on Semaglutide
The FDA has officially declared the end of the semaglutide shortage, leading to critical regulatory changes:
503A Compounding Pharmacies must cease semaglutide production by April 22, 2025.
503B Outsourcing Facilities may continue production until May 22, 2025.
At RxConnexion, we are partnered with 503B FDA-registered outsourcing facilities to ensure continued patient access to high-quality semaglutide formulations with extended Beyond-Use Dates (BUD)—helping your pharmacy manage inventory efficiently and provide uninterrupted care.
Expanding Your Reach with Telemedicine & Digital Marketing
Beyond securing product availability, we offer cutting-edge solutions to help you increase patient engagement and maximize dispensing:
✅ Telemedicine Integration – Seamlessly connect patients with licensed providers to generate more prescriptions for your pharmacy.
✅ Digital Marketing Solutions – Leverage highly targeted campaigns to attract new patients and educate existing ones on available treatments.
✅ Patient Engagement Strategies – Utilize our custom marketing assets, social media management, and direct outreach tools to drive awareness and demand.
Stay Ahead of Industry Changes
We are also monitoring the recent lawsuit filed by the Outsourcing Facilities Association (OFA) against the FDA, which challenges the removal of semaglutide from the drug shortage list. As the legal landscape evolves,
RxConnexion will keep you informed and ensure compliance every step of the way.
Now is the time to take advantage of the latest pharmacy technology and marketing solutions to increase patient engagement and boost your pharmacy’s growth. If you have any questions or want to explore how RxConnexion can support your success, we’re here to help!
Comments